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Abstract
Background:  Campylobacter  enteritis represents a risk factor for the development of
inflammatory bowel disease (IBD) via unknown mechanisms. As IBD patients exhibit inflammatory
responses to their commensal intestinal microflora, factors that induce translocation of commensal
bacteria across the intestinal epithelium may contribute to IBD pathogenesis. This study sought to
determine whether Campylobacter induces translocation of non-invasive intestinal bacteria, and
characterize underlying mechanisms.
Methods: Mice were infected with C. jejuni and translocation of intestinal bacteria was assessed by
quantitative bacterial culture of mesenteric lymph nodes (MLNs), liver, and spleen. To examine
mechanisms of Campylobacter-induced bacterial translocation, transwell-grown T84 monolayers
were inoculated with non-invasive Escherichia coli HB101 ± wild-type Campylobacter or invasion-
defective mutants, and bacterial internalization and translocation were measured. Epithelial
permeability was assessed by measuring flux of a 3 kDa dextran probe. The role of lipid rafts was
assessed by cholesterol depletion and caveolin co-localization.
Results: C. jejuni 81–176 induced translocation of commensal intestinal bacteria to the MLNs, liver,
and spleen of infected mice. In T84 monolayers, Campylobacter-induced internalization and
translocation of E. coli occurred via a transcellular pathway, without increasing epithelial
permeability, and was blocked by depletion of epithelial plasma membrane cholesterol. Invasion-
defective mutants and Campylobacter-conditioned cell culture medium also induced E. coli
translocation, indicating that C. jejuni does not directly 'shuttle' bacteria into enterocytes. In C. jejuni-
treated monolayers, translocating E. coli associated with lipid rafts, and this phenomenon was
blocked by cholesterol depletion.
Conclusion: Campylobacter, regardless of its own invasiveness, promotes the translocation of non-
invasive bacteria across the intestinal epithelium via a lipid raft-mediated transcellular process.
Background
Patients with IBD appear to display aberrant inflamma-
tory responses to their commensal intestinal microflora
via unknown mechanisms [1]. Normally, the intestinal
microflora is effectively confined to the lumen by the epi-
thelium. However, intestinal epithelial barrier defects
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may contribute to the development of IBD, as bacteria
that translocate through the epithelium may expose sub-
mucosal immune cells to inappropriate antigenic stimula-
tion and incite an inflammatory response towards the
commensal microflora [2]. In combination with genetic
and environmental factors, acute bacterial infection may
initiate or exacerbate inflammation in IBD patients [3-8].
While specific mechanisms involved remain unknown, it
is thought that the intestinal injury incurred during enteri-
tis may facilitate translocation of luminal antigens [7]. In
susceptible individuals, inflammation may become self
sustaining due to ineffective down-regulation, despite
elimination of the pathogen.
Intestinal bacteria can gain access to the lamina propria
via a paracellular route, in which bacteria translocate
between disrupted epithelial tight junctions ('leaky gut')
[2]. For example, there is a correlation between increased
intestinal paracellular permeability and bacterial translo-
cation [9], and bacteria have been observed within the
paracellular space of polarized enterocyte monolayers
[10]. Bacteria may also translocate across the intestinal
epithelium via a transcellular route, involving endocytic
uptake followed by intracellular trafficking. For example,
commensal intestinal bacteria have been observed within
the cytoplasm of enterocytes in patients with IBD, via
mechanisms that remain obscure [11]. As well, transloca-
tion of intestinal microflora can occur despite normal
intestinal paracellular permeability [12]. Furthermore,
translocation of non-invasive E. coli in enterocytes treated
with the proinflammatory cytokine, interferon gamma
(IFN-γ), occurs via a transcellular mechanism that pre-
cedes disruption in tight junction integrity [13].
Campylobacter species, including C. jejuni, C. coli, and C.
fetus, are one of the most prevalent causes of human acute
bacterial enteritis ('campylobacteriosis') in the developed
world [14]. Disease is typically self-limiting and character-
ized by fever, abdominal pain, and inflammatory diarrhea
[14]. Campylobacteriosis is the commonest risk factor for
post-infectious irritable bowel syndrome, which occurs in
≈20–30% patients following infection [15]. Moreover, for
reasons that are poorly understood, there is an increased
risk of developing IBD in the first year following campylo-
bacteriosis [4].
C. jejuni has been shown to disrupt the integrity of the
intestinal barrier by targeting epithelial tight junctions
[16,17]; however, whether this promotes translocation of
non-invasive luminal bacteria is unknown. Using comple-
mentary models in vivo and in vitro, the objectives of this
study were: (1) to determine whether Campylobacter
induces translocation of non-invasive bacteria; and (2) to
characterize underlying mechanisms. Results indicate that
Campylobacter may induce translocation of non-invasive
intestinal bacteria via a lipid raft-mediated transcellular
process.
Results
C. jejuni induces bacterial translocation of commensal 
bacteria in vivo
Large numbers (P < 0.01) of microaerobic bacteria were
isolated from the MLNs, liver, and spleen of C. jejuni-
treated mice (3.08 ± 0.46, 2.03 ± 0.77, 3.12 ± 0.69 log10
CFU/g, respectively), compared to control mice (0, 0, 0.43
± 0.43 log10 CFU/g, respectively). Bacteria were identified
as Proteus, Acinetobacter, and Pseudomonas. C. jejuni were
also isolated from the MLNs, liver, and spleen of all C.
jejuni-treated mice (8/8) but not from uninfected controls
(P < 0.001). AmpR E. coli were isolated from the MLNs of
3/8 and the spleen of 1/8 C. jejuni-treated mice, but were
not isolated from the liver of C. jejuni-treated mice, nor
the MLNs, liver, or spleen of control mice.
C. jejuni induces translocation of non-invasive E. coli 
across confluent epithelia
E. coli translocation was increased (P = 0.03) in C. jejuni-
treated monolayers (2.41 ± 0.23 log10 CFU/ml), com-
pared to controls (1.34 ± 0.17 log10 CFU/ml). E. coli inter-
nalization was also increased (P  = 0.04) in C. jejuni-
infected monolayers (2.09 ± 0.15 log10 CFU/ml), com-
pared to controls (2.83 ± 0.04 log10 CFU/ml). Permeabil-
ity was not different (P = 0.75) between treatments (0.035
± 0.011% versus 0.031 ± 0.009% apical FITC-dextran/
cm2/h for control and C. jejuni-treated monolayers,
respectively). E. coli were visualized within membrane-
bound vacuoles within the cytoplasm of C. jejuni-treated
monolayers (Figure 1), but were not observed in controls
(not shown).
C. jejuni-induced translocation of E. coli is cholesterol-
dependent
Treatment with MβCD or soluble cholesterol effectively
decreased (P < 0.001) or increased (P < 0.001) the choles-
terol of content of monolayers (9.68 ± 0.59, 1.78 ± 0.23,
24.18 ± 1.73 μg cholesterol/mg protein for untreated,
MβCD-treated, and cholesterol-treated monolayers,
respectively).
As observed previously, infection with C. jejuni signifi-
cantly increased E. coli internalization (P = 0.03). In C.
jejuni-treated monolayers, treatment with the lipid raft
disruptor MβCD inhibited E. coli internalization (P  =
0.04) and translocation (P = 0.04; Figure 2A and 2B).
Internalization and translocation of E. coli were not differ-
ent (P  = 0.60 and P  = 0.64, respectively), between C.
jejuni/MβCD-treated and untreated monolayers. In C.
jejuni-treated monolayers, there was increased internaliza-
tion (P = 0.03) but not translocation (P = 0.08) of E. coli
in monolayers that were treated with soluble cholesterolGut Pathogens 2009, 1:2 http://www.gutpathogens.com/content/1/1/2
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to augment plasma membrane cholesterol (Figure 2C and
2D). Internalization of E. coli in untreated and uninfected-
cholesterol-treated monolayers was not different (P  =
0.07). Cholesterol depletion and augmentation did not
affect the invasion or translocation C. jejuni (results not
shown).
Lipid rafts were isolated based on their buoyancy, by
sucrose gradient fractionation (Figure 3), and were
present in fractions 2 and 3 (as indicated by the presence
of the lipid raft marker, caveolin-1). Fluorescent E. coli
detected in fractions 2 and 3 represent lipid raft-associated
E. coli, whereas the fluorescence in fractions 6–8 repre-
sents extracellular E. coli. Infection with C. jejuni caused E.
coli to associate with lipid rafts. This effect was abolished
by cholesterol depletion with MβCD.
Epifluorescent microscopy was used to visualize the asso-
ciation of E. coli with cholesterol and caveolin-1 (Figure
4). Accumulations of cholesterol were observed in C.
jejuni-treated monolayers (Figure 4A), wherein E. coli were
co-localized (Figure 4A, B). E coli co-localized with caveo-
lin-1 in C. jejuni-treated monolayers (Figure 4C). Accumu-
lation of cholesterol and co-localization of E. coli with
cholesterol or caveolin-1 were not observed in control
monolayers (not shown).
E. coli translocation does not correspond with 
Campylobacter invasiveness
C. jejuni strains with various degrees of invasiveness were
used to assess whether E. coli translocation induced by the
bacterium corresponded with C. jejuni invasion. C. jejuni
81–176 was more invasive (P  < 0.001) than C. jejuni
CHR213 and C. fetus CHR105, as assessed by in vitro bac-
terial internalization assay (results not shown). Transloca-
tion of C. jejuni 81–176 (P = 0.003) and C. jejuni CHR213
(P = 0.02) was greater than that of C. fetus CHR105 (Fig-
ure 5A, black bars). Translocation of C. jejuni 81–176 and
C. jejuni CHR213 did not differ (P  = 0.45). All three
Campylobacter strains, regardless of their degree of inva-
siveness, significantly promoted (P ≤ 0.04) E. coli translo-
cation (Figure 5A, white bars); there was no difference (P
≥ 0.39) in the amount of E. coli translocation induced
among the three Campylobacter  strains. None of the
Campylobacter  strains caused changes in transepithelial
electrical resistance (TER) during the 4 h experimental
period (final TER was 97.7 ± 4.1%, 98.3 ± 6.8%, 94.0 ±
1.5%, and 85.6 ± 4.1% of the pre-treatment TER for con-
trol, C. jejuni 81–176, C. jejuni 213, and C. fetus CHR 105
– treated monolayers, respectively; P ≥ 0.18).
Since the presence of a functional flagellum is required for
C. jejuni invasion, studies assessed the ability of flagella
defective mutants to cause E. coli translocation. Isogenic
FlaAFlaB mutants of C. jejuni 81–176 and CHR213 were
less invasive than the wild-type (results not shown). Sim-
ilarly, translocation of the isogenic FlaAFlaB mutants of C.
jejuni 81–176 and CHR213 was less (P ≤ 0.004) than that
of the wild-type (Figure 5B). Translocation of E. coli across
the C. jejuni-treated monolayers did not differ (P ≥ 0.13)
between monolayers treated with the FlaAFlaB mutants or
the wild-type C. jejuni strains (Figure 5B). The final TER
did not differ between treatments (results not shown).
Internalization of E. coli was greater in monolayers treated
with live C. jejuni 81–176 (P < 0.001) and conditioned
cell culture media (P < 0.001), but not with paraformalde-
hyde-killed C. jejuni (Figure 6, P = 0.32). Similarly, E. coli
translocation was greater in monolayers treated with live
C. jejuni 81–176 (P = 0.005) and conditioned cell culture
medium (P = 0.002), but not paraformaldehyde-killed C.
jejuni (P = 0.77).
Discussion
Translocation of commensal bacterial antigens across the
intestinal epithelium occurs at a low rate through a highly
regulated process, and may play roles in establishing
immunological tolerance and mucosal surveillance [18-
20]. However, deregulation of this process is thought to
contribute to IBD. Since campylobacteriosis is a risk factor
for IBD [4,6], this study sought to determine whether
Campylobacter induces translocation of commensal bacte-
ria, and to characterize underlying mechanisms. The
Intracellular E. coli within Campylobacter-treated enterocytes Figure 1
Intracellular E. coli within Campylobacter-treated 
enterocytes. Non-invasive E. coli HB101 (green) is localized 
in a membrane-bound vacuole (red) within C. jejuni-treated 
T84 enterocytes. Note confocal sectioning (i.e., x-z and y-z 
planes) showing cytoplasmic localization of the E. coli. Bar, 3 
μM.Gut Pathogens 2009, 1:2 http://www.gutpathogens.com/content/1/1/2
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present findings indicate that C. jejuni increases transloca-
tion of intestinal bacteria to the MLNs, liver, and spleen of
infected mice. Results from in vitro studies demonstrate
that C. jejuni-induced translocation of non-invasive E. coli
occurred in the absence of altered permeability and was
mediated by lipid rafts. Moreover, wild type as well as
invasion-defective C. jejuni mutants were able to promote
translocation, but not paraformaldehyde-killed bacteria.
The effect appears to involve an extracellular bacterial
product that has yet to be identified. Together, the find-
ings outline a novel mechanism through which Campylo-
bacter  may promote the translocation of commensal
bacteria. Additional research is now needed to determine
whether this mechanism may explain at least in part, how
acute enteritis may contribute to inflammatory relapse in
patients with IBD.
Translocation of luminal bacteria may occur via paracellu-
lar and transcellular pathways. In vivo, bacteria may also
be transported to the MLNs and spleen by M cells or den-
dritic cells that sample luminal bacteria [18]. Thus, to
minimize confounding effects of these cells, we used T84
colonic monolayers to model the intestinal epithelium.
This also enabled assessment of the effect of invasion-
defective C. jejuni flagella mutants that do not readily col-
onize the intestinal tract of animals in vivo [21,22].
C. jejuni can disrupt enterocyte tight junctions, however
this effect is typically observed after prolonged incubation
(>24 h) [16,17]. Present findings indicate that C. jejuni
rapidly induces translocation of non-invasive E. coli across
an intact intestinal epithelium via a transcellular route
(i.e., <4 h post-infection). Thus, C. jejuni induces translo-
cation of non-invasive E. coli well in advance of tight junc-
tion disruption, via a transcellular pathway. This is
supported by the observed increase in the number of
intracellular E. coli detected within C. jejuni-treated ente-
rocytes using the gentamicin protection assay and confo-
Plasma membrane cholesterol affects C. jejuni-induced E. coli internalization and translocation Figure 2
Plasma membrane cholesterol affects C. jejuni-induced E. coli internalization and translocation. Cholesterol 
depletion prevents C. jejuni 81–176-induced (A) internalization, and (B) translocation of E. coli HB101 in confluent T84 monol-
ayers, 4 h post-infection. (n = 3). Increased plasma membrane cholesterol promotes C. jejuni 81–176-induced internalization 
(C) of E. coli, but does not affect E. coli translocation (D), 4 h post-infection. (n = 4). Data are means ± SEM, *P < 0.05 com-
pared to untreated non-infected monolayers. †P < 0.05 compared to untreated C. jejuni-infected monolayers.Gut Pathogens 2009, 1:2 http://www.gutpathogens.com/content/1/1/2
Page 5 of 10
(page number not for citation purposes)
cal laser imaging. Furthermore, the barrier function of C.
jejuni-treated monolayers remained intact (as indicated by
the lack of altered permeability or TER), despite increased
translocation.
While a broad range of enteropathogens, including C.
jejuni, are known to disrupt epithelial tight junctions and
increase paracellular permeability [23], very few studies
have examined the effect this has on bacterial transloca-
tion. Recently, Salmonella enterica was shown to concur-
rently disrupt tight junction integrity of T84 enterocyte
monolayers and promote translocation of both itself and
non-pathogenic  E. coli within 2 h post-infection [24].
Although the authors of this study did not consider the
transcellular pathway in their experimental design, their
results suggests that unlike C. jejuni, Salmonella induces
bacterial translocation via a paracellular mechanism.
In enterocytes, transcellular translocation of commensal
bacteria may occur during conditions of inflammatory
and metabolic stress [10,13], suggesting that Campylo-
bacter could be acting as a stressor and induce transloca-
tion via similar pathways as these stimuli. Current
findings are consistent with observations that enterocytes
of IBD patients display elevated transcellular antigen
transport [25,26], and occasionally contain intracellular
bacteria [11]. The mechanisms and signalling pathways
responsible for the increased internalization and translo-
cation of intestinal bacteria in enterocytes of IBD patiens
has yet to be examined.
Lipid rafts are cholesterol and sphingolipid enriched
microdomains of the plasma membrane that contain
numerous receptor and signalling molecules. Bacteria can
cross epithelial barriers via a transcellular route by exploit-
ing lipid rafts [27]. Lipid raft-mediated translocation may
be advantageous to translocating organisms, as bacteria
endocytosed via this process appear to avoid lysosomal
fusion [27]. As lipid raft-mediated endocytosis has been
recently shown to mediate transcellular translocation of
commensal  E. coli in IFNγ-stimulated enterocytes [13],
experiments assessed the involvement of lipid rafts in
mediating C. jejuni-induced E. coli translocation. A phar-
macological approach was used since confluent T84 ente-
rocytes are notoriously resistant to transfection [28].
Disruption of lipid rafts by cholesterol depletion pre-
vented C. jejuni-induced E. coli internalization and trans-
location. Conversely, increasing the plasma membrane
cholesterol potentiated C. jejuni-induced E. coli internali-
zation. In C. jejuni-treated monolayers, cholesterol deple-
tion also prevented association of E. coli with lipid rafts, as
determined by sucrose gradient fractionation. Addition-
ally, microscopic analysis reveled that E. coli co-localized
with the lipid raft markers, cholesterol and caveolin-1, in
C. jejuni-infected monolayers. C. jejuni also appears to
cause accumulation of cholesterol on the enterocyte sur-
face, possibly indicating the coalescence of lipid rafts,
making them available for exploitation by a normally
non-invasive E. coli strain. Similarly, it has been suggested
that raft coalescence may bring into close proximity,
endocytic signalling molecules and bacterial binding sites,
which in turn facilitate IFNγ-induced E. coli translocation
[13]. Taken together, these observations demonstrate for
the first time that C. jejuni may induce internalization of
non-invasive intestinal bacteria via lipid raft-mediated
endocytosis. Additional research is needed to further char-
acterize the molecular mechanisms of lipid raft-mediated
translocation in vivo. However, mice deficient in the lipid
raft regulatory protein, caveolin-1, display global defects
in innate immune responses and are more susceptible to
infection with enteric pathogens [29,30], which may
necessitate the development of mice with enterocyte-spe-
cific deletion of caveolin-1 to further advance these stud-
ies.
Invasive pathogens such as the dental pathogen, Fusobac-
terium nucleatum, can adhere to and directly transport
non-invasive Streptococcus into oral epithelial cells [31]. It
was recently observed that C. jejuni itself may translocate
enterocytes via lipid rafts [32] or via clathrin-mediated
C. jejuni promotes association of E. coli with lipid rafts Figure 3
C. jejuni promotes association of E. coli with lipid 
rafts. (A) Lipid rafts were isolated by sucrose gradient frac-
tionation and fluorescent E. coli in each fraction was meas-
ured (values are shown as relative fluorescence units (RFU)). 
Arrows indicate fractions containing lipid raft-associated E. 
coli. *P < 0.05 compared to control and cholesterol-depleted 
monolayers. Data are means ± SEM (n = 3). (B) Fractions 
were analyzed by western blot analysis for the lipid raft 
marker, caveolin-1. A representative image from three 
experiments is shown.Gut Pathogens 2009, 1:2 http://www.gutpathogens.com/content/1/1/2
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C. jejuni 81–176 causes accumulation of cholesterol and promotes co-localization of E. coli HB101 with lipid rafts Figure 4
C. jejuni 81–176 causes accumulation of cholesterol and promotes co-localization of E. coli HB101 with lipid 
rafts. Epifluorescent images demonstrating (A) accumulation of cholesterol (blue), and co-localization of E. coli (orange-red) 
with (A, B) cholesterol and (C) caveolin-1 (green), 4 h post-infection. DIC, differential interference contrast. N, nucleus. 
Arrows indicate co-localization of E. coli with lipid raft markers. Bar = 2 μM. Representative images are shown from two exper-
iments performed in quadruplicate.
Translocation of E. coli does not correspond with Campylobacter invasiveness Figure 5
Translocation of E. coli does not correspond with Campylobacter invasiveness. (A) Translocation of E. coli HB101 
(white bars) and Campylobacter (black bars) in T84 monolayers infected with highly (strain 81–176), moderately (CHR213), and 
modestly-invasive (CHR105) Campylobacter strains, 4 h post-infection. (B) Translocation of E. coli HB101 (white bars) and 
Campylobacter (black bars) in T84 monolayers treated with wild-type C. jejuni 81–176 and CHR213, and corresponding inva-
sion-defective FlaAFlaB mutants Data are means ± SEM (n = 3). *P < 0.05 compared to control monolayers. †P < 0.05 com-
pared to C. jejuni 81–176 and C. jejuni CHR213. ‡ P < 0.05 compared corresponding wild-type C. jejuni-treated monolayers.Gut Pathogens 2009, 1:2 http://www.gutpathogens.com/content/1/1/2
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endocytosis [33,34]. However, the present findings that
highly invasive (strain 81–176), moderately invasive
(CHR213), and modestly invasive campylobacter's
(CHR105 and FlaAFlaB mutants) caused equivalent E. coli
translocation, suggest that Campylobacter does not directly
'shuttle' non-invasive bacteria into enterocytes. Further-
more, conditioned media also induced E. coli internaliza-
tion and translocation, indicating that a hitherto
unidentified extracellular product may be responsible for
the observed effect.
Conclusion
Findings that Campylobacter disrupts intestinal epithelial
transcellular transport and promotes translocation of
non-invasive bacteria may have important implications in
mucosal inflammatory responses towards the intestinal
microflora. Future studies will assess whether and how
this inflammatory response may result in collateral dam-
age, or could exacerbate or initiate IBD in susceptible indi-
viduals. Campylobacter-infected enterocytes offer a unique
model for further investigation into mechanisms promot-
ing commensal translocation, and may improve our
understanding of the pathogenesis of inflammatory
bowel diseases.
Methods
Bacteria and culture conditions
C. jejuni 81–176, a reference clinical strain [35], was used
throughout this study. C. jejuni CHR213 and C. fetus
CHR105 are clinical isolates that were characterized as
previously described [36]. FlaAFlaB mutants of C. jejuni
81–176 and CHR213 were constructed and characterized
as described previously [36]. Intestinal colonization of
mice was reduced for the C. jejuni 81–176 FlaAFlaB
mutant (results not shown), confirming previous observa-
tions [21,22].
Inoculum was prepared by growing Campylobacter for 14–
16 h in CYE broth (37°C, 100 rpm, microaerobic atmos-
phere) [37]. E. coli HB101 was grown for 14–16 h in
Columbia broth (37°C, 100 rpm; Difco, Detroit, MI).
Fluorescent labelling of E. coli
E. coli were washed with NaHCO3 buffer (0.1 M, pH 8.3),
and incubated for 45 min in Alexa-488 carboxylic acid
succinimidyl ester (0.5 mg/ml NaHCO3 buffer; Molecular
Probes, Eugene, OR). E. coli were then washed and sus-
pended (≈109 CFU/ml) in PBS containing 2% NaHCO3
(mouse study) or antibiotic-free Dulbecco's modified
Eagle medium (DMEM)/F-12 (T84 studies). Labelling did
not affect bacterial viability (results not shown).
In vivo study
Mice (Balb/c; Charles River, Montreal, QC) were housed
at Agriculture and Agri-Food Canada, Lethbridge
(Alberta) under the guidelines established by the Cana-
dian Council on Animal Care. Procedures were approved
by institutional Animal Care and Biosafety Committee's.
Five-week-old female mice were inoculated with C. jejuni
81–176 (108 CFU in CYE containing 2% NaHCO3) or
sterile CYE (controls) by gavage on days one and two. To
examine translocation of a model commensal intestinal
bacterium, all mice were inoculated on day three with flu-
orescent non-invasive E. coli (108 CFU) transformed with
an ampicillin resistant (AmpR) plasmid (pGEM-T Easy,
Promega, Madison, WI). Four hours later, mice were euth-
anized and the MLNs, and sections of liver, spleen, and
ileum were aseptically removed. Fecal pellets were also
An extracellular product from C. jejuni may induce E. coli translocation Figure 6
An extracellular product from C. jejuni may induce E. coli translocation. (A) Internalization, and (B) translocation of 
E. coli HB101 is induced by live C. jejuni 81–176 and conditioned cell culture medium (CM), but not paraformaldehyde-fixed C. 
jejuni. Data are means ± SEM (n = 3). * P < 0.05 compared to controls.Gut Pathogens 2009, 1:2 http://www.gutpathogens.com/content/1/1/2
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collected prior to euthanasia. Tissues and feces were
weighed and homogenized in PBS. C. jejuni, microaerobic
bacteria, and E. coli were enumerated by spreading serial
dilutions of fecal or tissue homogenates onto Karmali
agar containing selective supplement SR167 (Oxoid,
Nepean, ON), non-selective Karmali agar, and MacCo-
nkey agar containing ampicillin (100 μg/ml; Difco),
respectively, and incubating media at 37°C in a microaer-
obic (C. jejuni, microaerobic bacteria) or ambient (E. coli)
atmosphere. Isolated bacteria were identified by PCR and
comparative 16S rRNA sequence analysis.
Epithelial cell culture
T84 human colonic epithelial cells (passages 5 to 15;
American Type Culture Collection, Manassas, VA) were
grown in DMEM/F-12 plus 10% foetal bovine serum, 200
mM L-glutamine, 100 U/ml penicillin, 100 μg/ml strepto-
mycin, 80 μg/ml tylosin, and incubated at 37°C and 5%
CO2. Medium was replenished every 2 to 3 days. For trans-
location studies, cells were seeded onto Transwell filters at
4 × 105 cells/filter (5 μm pore size, 1.13 cm2; Costar, Corn-
ing Inc. Corning, NY). Transepithelial electrical resistance
(TER) was monitored with an electrovoltohmeter (World
Precision Instruments, Sarasota, FL), and monolayers
were used at confluence (TER > 1000 Ω/cm2). For micros-
copy, cells were seeded into Lab-Tek chamber slides at 8 ×
104 cells/well (Nalgene Nunc International, Naperville,
IL).
In vitro bacterial translocation and internalization assay
Monolayers were washed with PBS and antibiotic-free
DMEM/F12 was added to the apical and basal compart-
ments. Monolayers were inoculated apically with E. coli ±
Campylobacter or to achieve a MOI of 100 CFU/enterocyte
for each bacterial species. Control monolayers received an
equivalent volume of CYE. Following 4 h incubation in
microaerobic conditions, E. coli and Campylobacter recov-
ered in the basal compartment medium were enumerated
by spreading serial dilutions onto non-selective Karmali
agar and incubating microaerobically at 37°C. These con-
ditions are suitable for the growth of E. coli and Campylo-
bacter. T84 cells maintain TER > 1000 Ω/cm2 for > 24 in
microaerobic atmosphere (data not shown).
To assess E. coli internalization, monolayers washed with
PBS and incubated for 1 h with DMEM/F12 containing
gentamicin (250 μg/ml; Sigma-Aldrich, Oakville, ON)
[10]. Monolayers were washed, lysed with 0.1% Triton X-
100/PBS, and viable bacteria were enumerated. A prelim-
inary experiment confirmed that E. coli were killed by the
gentamicin treatment. Campylobacter internalization was
determined as for E. coli, except monolayers were incu-
bated for 3 h with DMEM/F12 containing gentamicin
(500 μg/ml), as described previously [36].
For some experiments, apical compartments were inocu-
lated with E. coli ± paraformaldehyde-fixed C. jejuni 81–
176 or apical medium was replaced with conditioned
DMEM/F12. Paraformaldehyde-fixed C. jejuni were pre-
pared by incubating bacteria for 2 h in 2% paraformalde-
hyde. Cells were washed and suspended in antibiotic-free
DMEM/F12 (≈109  CFU/ml). To prepare conditioned
medium, T84 monolayers (75 cm2 flask) were washed
with PBS, and antibiotic-free DMEM/F12 was added to
the flask. Cells were inoculated with C. jejuni 81–176
(MOI 100) and incubated microaerobically overnight
(37°C). Media was clarified by centrifugation, followed
by filtration through a 0.2 μM syringe filter. Sterility was
confirmed by viable counting.
Epithelial permeability
Following the infection period, monolayers were washed
with sterile Ringer's solution. A 3 kDa FITC-dextran probe
(500 μl, 100 mM in Ringer's solution; Molecular Probes)
was added to the apical compartment, and 1 ml of
Ringer's solution added to the basal compartment and
incubated for 3 h at 37°C, as describe previously [38].
Samples were collected from the basal compartment and
absorbance485 was measured. Data were expressed as %
apical dextran/cm2/h.
Manipulation of plasma membrane cholesterol
Disruption of lipid rafts was performed by membrane
cholesterol depletion as validated previously. Monolayers
received MβCD (50 mM or 10 mM; Sigma) plus lovastatin
(1 μM; Sigma) 30 min prior to inoculation. Conversely,
plasma membrane cholesterol was increased by incubat-
ing monolayers for 4 h with soluble βCD-complexed cho-
lesterol (100 μM; Sigma) and washing with PBS prior to
inoculation. These treatments did not affect viability of
T84 cells, C. jejuni, or E. coli (results not shown). Plasma
membrane cholesterol was measured using an Amplex red
cholesterol assay kit (Molecular Probes). Total protein
was measured using a Bradford protein assay (Bio-Rad
Laboratories, Hercules, CA).
Microscopy
T84 apical membranes were fluorescently labelled by
washing monolayers with Hank's buffered saline (HBSS)
and incubating with Alexa-546 carboxylic acid succinimi-
dyl ester (0.5 mg/ml HBSS, 1 h, 4°C, Molecular Probes).
Monolayers were washed and inoculated with Alexa488-
labelled E. coli ± C. jejuni, as described for the transloca-
tion assay. After incubation, slides were washed with PBS,
and fixed in paraformaldehyde (2%). Optical sectioning
was carried out by confocal laser microscopy (Leica
Microsystems GmbH, Wetzler, Germany). Digitized
images were analyzed with Imaris software (Bitplane AG,
Zurich, Switzerland).Gut Pathogens 2009, 1:2 http://www.gutpathogens.com/content/1/1/2
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To visualize cholesterol-rich domains, T84 cells were
stained with the fluorescent sterol-binding drug, filipin
(0.5 mM in PBS; Sigma), for 30 min [39]. To stain for
caveolin-1, slides were rinsed with PBS, incubated with
glycine (1% in PBS) for 15 min, and rinsed with PBS. Cells
were permeabilized for 10 min with Triton X-100 (0.5%
in PBS), blocked with BSA (2% in PBS), incubated with
mouse anti-caveolin-1 antibodies (1/100 dilution in PBS;
BD Bioscience, San Diego, CA) followed by Alexa-488
conjugated anti-mouse IgG (1/100 dilution in PBS;
Molecular Probes).
Lipid raft isolation
Another set of experiments characterized the association
of translocating E. coli with lipid rafts. Monolayers were
inoculated with fluorescent E. coli ± C. jejuni as described
for the translocation assay. Lipid rafts were isolated by
sucrose gradient fractionation, as previously described
[39,40]. For each of eight fractions that were collected, flu-
orescent  E. coli were quantified by measuring
absorbance485, and the lipid raft marker, caveolin-1, was
detected by western blot analysis using mouse anti-caveo-
lin-1 antibodies (1/1000 dilution; BD Bioscience), and
HRP-conjugated anti-mouse IgG antibodies (1/5000 dilu-
tion; Sigma) [39].
Statistical analysis
Experiments were conducted ≥ three times independently.
Assays were conducted at least in triplicate, and mean val-
ues were used for analysis. Analyses were performed with
GraphPad InStat software (GraphPad Software Inc., San
Diego, CA). Data are expressed as means ± SEM. Data with
≥ three treatments were compared by one way ANOVA,
followed by the protected Tukey-Kramer multiple com-
parison test. Data with two treatments were compared
using an unpaired Student's t-test. Translocation inci-
dences in mice were compared using the Fisher's exact
test. P ≤ 0.05 was considered significant.
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